David Sourdive

Venture Partner

David is a co-founder, Executive Vice President for Strategic Initiatives and Director of Cellectis. He is also serving at the Board of Directors of EnobraQ SAS, Eukarÿs SAS as well as at the strategic board of OmicX SAS in industry, as well as the Board of Director of the Mediterranean Insitute For Life Sciences, in academia.

David has a 20 years entrepreneurial experience, taking Cellectis from foundation as a technology concept-based startup to a clinical-stage both NasdaQ and Euronext listed bio-pharmaceutical company, raising over 500 million euros with private investors, then through IPOs and follow-ons. He combines scientific expertise with development skills bringing innovative technologies to industrial fruition.

David’s career started in industrial program management at the French Department of Defense (DGA) prior to Cellectis’ inception.

Education

École Polytechnique

Ph.D. in molecular virology at Institut Pasteur

Research fellowship in the Emory University Department of Microbiology and Immunology

Expertise

Biotechnology